InvestorsHub Logo
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: JG36 post# 65719

Wednesday, 02/20/2013 12:34:08 AM

Wednesday, February 20, 2013 12:34:08 AM

Post# of 146240
Yeah, that's what I thought you would do, post some data showing huge costs and total expenditures for extremely expensive treatments, but nothing showing the per patient cost anywhere near $45,000. I was hoping you would pull at least 1 clinical trial that showed per patient costs over $6K, but I guess you can't even do that.

That's why I posted the ATZ discovery, development, and trial costs. We already know these can be pretty expensive when dealing with exotic or emerging disease. Dengue costs now exceed $15 billion, ($3 billion for Novartis vaccines alone, but they had a trial with 35K patients in Phase 3 before the vaccine was pulled.) so what? What does oncology costs have to do with the taste of oranges?

If it's there in your link please provide which drug it was and where it is on the page, because I missed it. Still a fabrication as far as I'm concerned.

Flu trials are much cheaper, so you got any relevant data on those costs per patient? Or do you want to pull out some more RNAi trials?

"It ain't what they call you, it's what
you answer to." --WC Fields

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News